Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of DNA double-strand break repair pathway choice
$431,208Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2024 · CA
Radioimmunotherapy Combinations for B-cell Malignancy
$431,181Damian J. Green · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,094Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2021 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer
$431,028Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Pathology Core
$430,936Geoffrey I Shapiro · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$430,781Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Project 3: A novel telomere-targeted agent for neoadjuvant therapy of early-stage HCC
$430,751Adam Yopp · Ut Southwestern Medical Center · P50 · FY2025 · CA
Mutational signature analysis: methods and applications to the clinic
$430,741Peter Park · Harvard Medical School · R01 · FY2024 · CA
Studies of DNA damage checkpoints
$430,729Paul R Russell · Scripps Research Institute, The · R01 · FY2006 · CA
3' RNA modification enzymes regulate tumor angiogenesis in non-small lung cancer
$430,684Seyedtaghi Takyar · Yale University · R21 · FY2024 · CA
Tumor cell -TAM Paracrine Signaling in Breast Cancer
$430,489Elizabeth S. Yeh · Indiana University Indianapolis · R01 · FY2024 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$430,481Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
The integrated stress response and the microenvironment in melanoma progression
$430,251Constantinos Koumenis · University Of Pennsylvania · R01 · FY2022 · CA
Rare Central Nervous System Cancers Initiative
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Brain Tumor Immunotherapy
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Project 2
$430,137Rory Smoot · Mayo Clinic Rochester · P50 · FY2024 · CA
Project 1: Glutaminolytic GDH1 activation-dependent immunotherapy resistance in LKB1-mutant lung adenocarcinoma
$430,062Sumin Kang · Emory University · P01 · FY2022 · CA
Elucidating the critical role of Wee1 in GIST
$430,050Lori Rink · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Elucidating the critical role of Wee1 in GIST
$430,050Lori Rink · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$429,841Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
An integrated polymeric carrier for subunit cancer vaccines
$429,683Suzie H Pun · University Of Washington · R01 · FY2021 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA